Taiwan · Delayed Price · Currency is TWD TWi Biotechnology Statistics
Total Valuation
TPEX:6610 has a market cap or net worth of TWD 3.77 billion. The enterprise value is 3.44 billion.
| Market Cap | 3.77B |
| Enterprise Value | 3.44B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6610 has 107.63 million shares outstanding. The number of shares has increased by 5.63% in one year.
| Current Share Class | 107.63M |
| Shares Outstanding | 107.63M |
| Shares Change (YoY) | +5.63% |
| Shares Change (QoQ) | +0.76% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 5.29% |
| Float | 43.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 14.03 |
| P/TBV Ratio | 15.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -22.18 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -26.28 |
Financial Position
The company has a current ratio of 2.78, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.78 |
| Quick Ratio | 2.77 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -1,196.70 |
Financial Efficiency
Return on equity (ROE) is -60.59% and return on invested capital (ROIC) is -36.85%.
| Return on Equity (ROE) | -60.59% |
| Return on Assets (ROA) | -27.83% |
| Return on Invested Capital (ROIC) | -36.85% |
| Return on Capital Employed (ROCE) | -56.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -6.75M |
| Employee Count | 23 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +132.89% in the last 52 weeks. The beta is 0.59, so TPEX:6610's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +132.89% |
| 50-Day Moving Average | 29.55 |
| 200-Day Moving Average | 17.40 |
| Relative Strength Index (RSI) | 59.03 |
| Average Volume (20 Days) | 1,002,525 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -154.37M |
| Pretax Income | -155.28M |
| Net Income | -155.28M |
| EBITDA | -147.28M |
| EBIT | -154.37M |
| Earnings Per Share (EPS) | -1.77 |
Balance Sheet
The company has 332.56 million in cash and 4.28 million in debt, giving a net cash position of 328.28 million or 3.05 per share.
| Cash & Cash Equivalents | 332.56M |
| Total Debt | 4.28M |
| Net Cash | 328.28M |
| Net Cash Per Share | 3.05 |
| Equity (Book Value) | 268.86M |
| Book Value Per Share | 2.50 |
| Working Capital | 214.34M |
Cash Flow
In the last 12 months, operating cash flow was -130.92 million and capital expenditures -146,000, giving a free cash flow of -131.07 million.
| Operating Cash Flow | -130.92M |
| Capital Expenditures | -146,000 |
| Free Cash Flow | -131.07M |
| FCF Per Share | -1.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6610 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.63% |
| Shareholder Yield | -5.63% |
| Earnings Yield | -4.12% |
| FCF Yield | -3.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |